{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:02:33Z","timestamp":1790715753275,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":302,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["82,505,809"],"award-info":[{"award-number":["82,505,809"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,174,307"],"award-info":[{"award-number":["82,174,307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,305,138"],"award-info":[{"award-number":["82,305,138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinsp.2025.100823","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T19:45:03Z","timestamp":1762371903000},"page":"100823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The risk factors of anti-neutrophil cytoplasmic antibody-associated vasculitis-associated interstitial lung disease: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1756-1045","authenticated-orcid":false,"given":"Ningxia","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6152-1040","authenticated-orcid":false,"given":"Shuguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8122-8626","authenticated-orcid":false,"given":"Danyang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3862-7908","authenticated-orcid":false,"given":"Lili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2423-808X","authenticated-orcid":false,"given":"Ruonan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0281-322X","authenticated-orcid":false,"given":"Xueqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clinsp.2025.100823_bib0001","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.42976","article-title":"Relapse prediction in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"76","author":"Nic","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100823_bib0002","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.31477","article-title":"Spectrum of pulmonary manifestations in antineutrophil cytoplasmic antibody-associated vasculitis on chest CT","volume":"224","author":"Mok","year":"2025","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100823_bib0003","doi-asserted-by":"crossref","first-page":"E678","DOI":"10.1016\/j.chest.2021.07.043","article-title":"The clinical relevance of infection and its treatment in microscopic polyangiitis with or without interstitial lung disease response","volume":"160","author":"Yasuma","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.clinsp.2025.100823_bib0004","doi-asserted-by":"crossref","first-page":"m1070","DOI":"10.1136\/bmj.m1070","article-title":"ANCA associated vasculitis","volume":"369","author":"Hunter","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100823_bib0006","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.autrev.2017.05.008","article-title":"Interstital lung disease in ANCA vasculitis","volume":"16","author":"Alba","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0007","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12890-022-01829-y","article-title":"Pulmonary involvement of ANCA-associated vasculitis in adult Chinese patients","volume":"22","author":"Zhou","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"162","key":"10.1016\/j.clinsp.2025.100823_bib0008","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0123-2021","article-title":"Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0009","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat rev Dis Primers"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100823_bib0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000529085","article-title":"Patterns of interstitial lung disease and prognosis in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"102","author":"Zhou","year":"2023","journal-title":"Respiration"},{"key":"10.1016\/j.clinsp.2025.100823_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102338","article-title":"Usual interstitial pneumonia in ANCA-associated vasculitis: a poor prognostic factor","volume":"106","author":"Maillet","year":"2020","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0012","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1183\/09031936.00110109","article-title":"Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis","volume":"36","author":"Tzelepis","year":"2010","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100823_bib0013","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.39475","article-title":"Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis: a multicenter, longitudinal, retrospective study of one hundred fifty consecutive hospital-based Japanese patients","volume":"68","author":"Yamagata","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/rheumatology\/kev286","article-title":"Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort","volume":"55","author":"Schirmer","year":"2016","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100823_bib0015","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/rheumatology\/ker236","article-title":"Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study","volume":"50","author":"Arulkumaran","year":"2011","journal-title":"Rheumatol (Oxf)"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100823_bib0016","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00408-022-00532-3","article-title":"Serum oncomarkers in patients with MPO-ANCA-positive vasculitis: diagnostic and prognostic predictive values for interstitial lung disease","volume":"200","author":"Yang","year":"2022","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100823_bib0017","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.chest.2021.01.083","article-title":"Clinical significance of interstitial lung disease and its acute exacerbation in microscopic polyangiitis","volume":"159","author":"Hozumi","year":"2021","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100823_bib0018","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2169\/internalmedicine.40.1093","article-title":"Serum levels of KL-6 reflect disease activity of interstitial pneumonia associated with ANCA-related vasculitis","volume":"40","author":"Iwata","year":"2001","journal-title":"Intern Med"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100823_bib0019","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1093\/rheumatology\/keab064","article-title":"CCL2 produced by CD68+\/CD163+ macrophages as a promising clinical biomarker of microscopic polyangiitis-interstitial lung disease","volume":"60","author":"Matsuda","year":"2021","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.clinsp.2025.100823_bib0020","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.clinsp.2025.100823_bib0021","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"7650","key":"10.1016\/j.clinsp.2025.100823_bib0022","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0023","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100823_bib0024","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"issue":"12","key":"10.1016\/j.clinsp.2025.100823_bib0025","first-page":"185","article-title":"Analysis of clinical features of ANCA-associated vasculitis complicated with interstitial lung disease","volume":"9","author":"Jiang","year":"2023","journal-title":"World J Complex Med"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100823_bib0026","first-page":"1111","article-title":"Analysis of clinical characteristics and influence factors of lung involvement in ANCA-associated vasculitis","volume":"45","author":"Miao","year":"2023","journal-title":"J Ningxia Med Univ"},{"issue":"01","key":"10.1016\/j.clinsp.2025.100823_bib0027","first-page":"35","article-title":"ANCA-associated vasculitis with interstitial lung disease: clinical manifestations, imaging features and prognostic analysis","volume":"35","author":"Wu","year":"2024","journal-title":"J China Clin Med Imaging"},{"issue":"04","key":"10.1016\/j.clinsp.2025.100823_bib0028","first-page":"340","article-title":"Clinical and imaging features of anti-neutrophil cytoplasmicantibodies associated vasculitis with interstitial lung disease","volume":"49","author":"Zhang","year":"2023","journal-title":"Jiangsu Med J"},{"issue":"14","key":"10.1016\/j.clinsp.2025.100823_bib0029","first-page":"2504","article-title":"Clinical characteristics and prognosis of antineutrophil cytoplasmic antibody associated vasculitis with interstitial lung disease","volume":"30","author":"Xie","year":"2021","journal-title":"Henan Med Res"},{"issue":"08","key":"10.1016\/j.clinsp.2025.100823_bib0030","first-page":"983","article-title":"Clinical value of serum KL-6, DD and CRP in ANCA-associated vasculitis with interstitial lung disease","volume":"37","author":"Tan","year":"2021","journal-title":"Chin J Immunol"},{"issue":"30","key":"10.1016\/j.clinsp.2025.100823_bib0031","first-page":"43","article-title":"Analysis of clinical features of ANCA associated vasculitis with interstitial pneumonia","volume":"19","author":"Wang","year":"2019","journal-title":"World Latest Med Inf"},{"issue":"07","key":"10.1016\/j.clinsp.2025.100823_bib0032","first-page":"1165","article-title":"Analysis of serum KL - 6 level in patients with antineutrophil cytoplasm antibody associated vasculitis and pulmonary interstitial disease","volume":"28","author":"Liu","year":"2019","journal-title":"Henan Med Res"},{"issue":"08","key":"10.1016\/j.clinsp.2025.100823_bib0033","first-page":"805","article-title":"An analysis of influencing faetors for ANCA-associated vasculitis complicated with interstitial lung disease","volume":"49","author":"Jiang","year":"2023","journal-title":"Jiangsu Med J"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100823_bib0034","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/rheumatology\/kead444","article-title":"Prediction model for respiratory-related mortality in microscopic polyangiitis with interstitial lung disease: multicentre REVEAL cohort study","volume":"63","author":"Matsuda","year":"2024","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2214\/AJR.18.20967","article-title":"Chest high-resolution CT findings of microscopic polyangiitis: a Japanese first nationwide prospective cohort study","volume":"213","author":"Suzuki","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100823_bib0036","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10067-014-2676-1","article-title":"Microscopic polyangiitis associated with pulmonary fibrosis","volume":"34","author":"Fernandez Casares","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0037","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/biology11010094","article-title":"KL-6 in ANCA-associated vasculitis patients with and without ILD: a machine learning approach","volume":"11","author":"Conticini","year":"2022","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100823_bib0038","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/keac339","article-title":"Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality","volume":"62","author":"Doliner","year":"2023","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100823_bib0039","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3899\/jrheum.220123","article-title":"Association of M2 macrophages, Th2, and B cells with pathomechanism in microscopic polyangiitis complicated by interstitial lung disease","volume":"49","author":"Matsuda","year":"2022","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0040","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/s41598-021-81311-7","article-title":"Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease","volume":"11","author":"Matsuda","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100823_bib0041","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar4550","article-title":"Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study","volume":"16","author":"Sada","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100823_bib0042","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/annrheumdis-2018-214263","article-title":"Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis","volume":"78","author":"Namba","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.clinsp.2025.100823_bib0043","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s10067-015-2967-1","article-title":"Reduced survival in microscopic polyangiitis patients with pulmonary fibrosis in a respiratory referral centre","volume":"34","author":"Flores-Su\u00e1rez","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100823_bib0044","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.chest.2019.05.014","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in North American patients with idiopathic pulmonary fibrosis","volume":"156","author":"Liu","year":"2019","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0045","article-title":"Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis","volume":"2","author":"Kagiyama","year":"2015","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.clinsp.2025.100823_bib0046","doi-asserted-by":"crossref","first-page":"i83","DOI":"10.1093\/ndt\/gfu385","article-title":"Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan","volume":"30","author":"Hirayama","year":"2015","journal-title":"Nephrol Dial Transpl"},{"issue":"24","key":"10.1016\/j.clinsp.2025.100823_bib0047","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MD.0000000000000217","article-title":"Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature","volume":"93","author":"Comarmond","year":"2014","journal-title":"Med (Baltim)"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100823_bib0048","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Resp Crit Care"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100823_bib0049","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.rmed.2008.04.023","article-title":"ANCA-associated lung fibrosis: analysis of 17 patients","volume":"102","author":"Foulon","year":"2008","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100823_bib0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2010.04.003","article-title":"Microscopic polyangiitis","volume":"36","author":"Chung","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100823_bib0051","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","article-title":"Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides","volume":"9","author":"Homma","year":"2004","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100823_bib0052","first-page":"351","article-title":"Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?","volume":"3","author":"Bhanji","year":"2010","journal-title":"NDT Plus"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100823_bib0053","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/s10165-011-0525-5","article-title":"Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study","volume":"22","author":"Ozaki","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100823_bib0054","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00296-011-2079-4","article-title":"Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea","volume":"32","author":"Ahn","year":"2012","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100823_bib0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10157-009-0250-y","article-title":"Mizoribine reduces serum KL-6 levels in ANCA-associated vasculitis","volume":"14","author":"Fujita","year":"2010","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100823_bib0056","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13730-013-0074-1","article-title":"Monitoring with serum SP-A, sp-D, and KL-6 in a patient with interstitial pneumonia complicated with ANCA-associated glomerulonephritis","volume":"3","author":"Takahashi","year":"2014","journal-title":"CEN Case Rep"},{"issue":"9","key":"10.1016\/j.clinsp.2025.100823_bib0057","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/jcm8091447","article-title":"Mucins as a new frontier in Pulmonary fibrosis","volume":"8","author":"Ballester","year":"2019","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100823_bib0058","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","article-title":"Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases","volume":"165","author":"Ohnishi","year":"2002","journal-title":"Am J Resp Crit Care"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100823_bib0059","first-page":"221","article-title":"Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis","volume":"38","author":"Sebastiani","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100823_bib0060","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinsp.2025.100823_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152307","article-title":"HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up","volume":"63","author":"Villeneuve","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100823_bib0062","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s10067-018-4067-5","article-title":"Birmingham vasculitis activity and chest manifestation at diagnosis can predict hospitalised infection in ANCA-associated vasculitis","volume":"37","author":"Yoo","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clinsp.2025.100823_bib0063","article-title":"Cross-sectional research: a critical perspective, use cases, and recommendations for IS research","volume":"70","author":"Maier","year":"2023","journal-title":"Int J Inf Manag"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225002418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225002418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:04:02Z","timestamp":1790712242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593225002418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":63,"alternative-id":["S1807593225002418"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100823","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk factors of anti-neutrophil cytoplasmic antibody-associated vasculitis-associated interstitial lung disease: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100823"}}